Skip to main content
Journal of Crohn's & Colitis logoLink to Journal of Crohn's & Colitis
. 2025 Sep 15;19(8):jjaf123. doi: 10.1093/ecco-jcc/jjaf123

Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

PMCID: PMC12448573  PMID: 40971653

This is a correction to: Daniele Noviello, María Chaparro, Chiara Viganò, Andreas Blesl, Brigida Barberio, Henit Yanai, Ambrogio Orlando, Rocío Ferreiro-Iglesias, Cristina Bezzio, Alessandra Zilli, Tamás Molnár, Cristian Gheorghe, Francesco Conforti, Tommaso Innocenti, Simone Saibeni, Peter Bossuyt, Raquel Oliveira, Anna Maria Carvalhas Gabrielli, Alessandra Losco, Sophie Vieujean, Enrico Tettoni, Lorena Pirola, Silvia Calderone, Maya Kornowski Cohen, Gabriele Dragoni, Timo Rath, Manuel Barreiro-de Acosta, Edoardo Vincenzo Savarino, Javier P. Gisbert, Maurizio Vecchi, Raja Atreya, Flavio Caprioli, Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study, Journal of Crohn’s and Colitis, Volume 19, Issue 5, May 2025, jjaf056, https://doi.org/10.1093/ecco-jcc/jjaf056

The following changes have been made to the originally published manuscript. The name of the 29th co-author has been emended to read: “Javier P. Gisbert” instead of: “Javier Perez Gisbert”.


Articles from Journal of Crohn's & Colitis are provided here courtesy of Oxford University Press

RESOURCES